Clinical Trial Update: Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler® [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the onset of action of Formoterol Turbuhaler in adults with chronic obstructive pulmonary disease. The study is completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Formoterol Turbuhaler (formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-10-25